Serum Institute CEO Adar Poonawalla reconfirmed Covishield-vaccinated Indians facing troubles with travel to the European Union. In light of the EU’s new ‘vaccine passport’ strategy not acknowledging the India-made version of the AstraZeneca-Oxford University antibody.
Mr Poonawalla stated he forwarded this at highest levels… with regulators and diplomatic and he expects the matter settle soon.
“I comprehend that a lot of Indians obtained COVISHIELD facing troubles with travel to the E.U., I have escalated this at the highest levels and expect to settle soon, both with regulators and at a diplomatic level with nations,” he said.
European Medicines Agency endorsed four vaccines, including the AstraZeneca shot developed and sold in Europe as Vaxzervria.
It has not, anyhow, sanctioned the version developed by the Serum Institute, retailed in India as Covishield.
Commencing July 1 EU initiate a ‘digital Covid certificate’ to “facilitate safe (and) free movement of citizens in the EU.”. The ‘certificate’ designed as proof the holder either inoculated, holds a negative probe result or has recuperated from contamination.
Passengers from outside the EU will necessary to hold one of these ‘certificates’ – acknowledged by all member-nations – that will permit restriction-free movement within the bloc.
Hence, under approved norms Indians who have been vaccinated with Covishield will not be qualified for a restriction-free travel within the European Union, and will be subject to confinement and other medical protocols imposed by each country.
Stay tuned with Artifex.News for further updates. Stay Connected, Stay Informed!
Image Credit: Wikimedia Commons.